SCHEMBL17997989

SCHEMBL17997989

CCc1nc2ccccc2c2c1ncc1ccccc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.44
GPR3 P46089 1/20 0.44
POLB P06746 1/20 0.42
RAD52 P43351 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
GAA P10253 2/20 0.39
MAPT P10636 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
PDGFRB P09619 1/20 0.38
PDGFRA P16234 1/20 0.38
ALDH1A1 P00352 2/20 0.38
HPGD P15428 2/20 0.38
LMNA P02545 1/20 0.38
MAPK1 P28482 1/20 0.38
HSD17B10 Q99714 1/20 0.38
KMT2A Q03164 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.37
PIM1 P11309 2/20 0.36
PIM3 Q86V86 1/20 0.36
TNKS2 Q9H2K2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17036576 0.76 POLB (0.49) KDM4EPOLBRAD52SMN1; SMN2GAA
SCHEMBL17997990 0.75 MAPT (0.49) KDM4EPOLBRAD52SMN1; SMN2GAA
SCHEMBL19009449 0.74 KDM4E (0.47) KDM4EGPR3POLBRAD52SMN1; SMN2
SCHEMBL18748049 0.73 POLB (0.50) KDM4EPOLBRAD52SMN1; SMN2GAA
SCHEMBL19051729 0.73 POLB (0.49) KDM4EGPR3POLBRAD52SMN1; SMN2
SCHEMBL19009455 0.72 POLB (0.45) KDM4EGPR3POLBRAD52SMN1; SMN2
SCHEMBL19051731 0.72 NPSR1 (0.46) KDM4EPOLBRAD52SMN1; SMN2GAA
SCHEMBL5801178 0.71 KDM4E (0.52) KDM4EGPR3SMN1; SMN2MAPTALDH1A1
SCHEMBL19009451 0.71 POLB (0.44) KDM4EGPR3POLBRAD52SMN1; SMN2
SCHEMBL16535869 0.70 KDM4E (0.48) KDM4EGPR3ALDH1A1HPGDMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160233434-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2016-08-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160233434-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME LEF1, OR51E2, OR10J3 KDM4E 2921/4885GPR3 2990/4885POLB 2639/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.